SELECTED PUBLICATIONS
- F. Fazioli, M. Resnati, N. Sidenius, Y. Higashimoto, E. Appella, F. Blasi.
A UROKINASE-SENSITIVE REGION OF THE HUMAN UROKINASE RECEPTOR IS RESPONSIBLE FOR ITS CHEMOTACTIC ACTIVITY. EMBO J. 16, 7279-7286 (1997)
- NS. Ambartsumian, MS. Grigorian, IF. Larsen, O. Karlström, N. Sidenius, J. Rygaard, GP. Georgiev and EM. Lukanidin. METASTASIS OF MAMMARY CARCINOMAS IN GRS/A HYBRID MICE TRANSGENIC FOR THE MTS1 GENE. Oncogene 13, 1621-1630 (1996)
- M. Resnati, M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi and F. Fazioli. PROTEOLYTIC CLEAVAGE OF THE UROKINASE RECEPTOR SUBSTITUTES FOR THE AGONIST-INDUCED CHEMOTACTIC EFFECT. EMBO J. 15, 1572-1582 (1996)
- M. Conese, U. Cavallero, N. Sidenius, D. Olson, M.R. Soria and F. Blasi. PMA-INDUCED DOWN REGULATION OF THE RECEPTOR FOR a2-MACROGLOBULIN IN HUMAN U937 CELLS. FEBS letters 358, 73-78 (1995)
- H. Solberg, J. Rømer, N. Brünner, A. Holm, N. Sidenius, K. Danø and G. Høyer-Hansen. A CLEAVED FORM OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN INVASIVE TRANSPLANTED HUMAN AND MURINE TUMORS. International Journal of Cancer 58, 877-881 (1994)
|